The Nathan S. Kline Institute for Psychiatric Research, Clinical Research, NYU Langone Health, Adult Psychiatry, New York, NY.
The Nathan S. Kline Institute for Psychiatric Research, Clinical Research, NYU Langone Health, Adult Psychiatry, New York, NY.
Psychosomatics. 2019 Jul-Aug;60(4):393-401. doi: 10.1016/j.psym.2018.10.002. Epub 2018 Oct 31.
Although most studies have suggested that mitral valve prolapse (MVP) is more prevalent in patients with panic disorder (PD) than in healthy controls, there is a substantial uncertainty in the rates of MVP across studies.
To investigate, through systematic review and meta-analysis, the relative risk of MVP in patients with PD compared to controls.
Embase, Proquest, Pubmed, and Google Scholar electronic databases were searched up to September 2018. All studies published in peer-reviewed journals, which included both PD and controls groups, were selected. Events (presence of MVP) and nonevents (absence of MVP) in PD and control groups were recorded. The main outcome was the measure of relative risk (RR) pooled with 95% confidence intervals, using fixed-effects model. Heterogeneity, small publication effect, and publication bias were evaluated.
Fourteen studies, including 1146 participants, met eligibility criteria. There was no significant heterogeneity or publication bias. The prevalence of MVP in PD and healthy controls was 27.20% and 9.21%, respectively. Patients with PD had a significantly increased relative risk of MVP compared to controls in the pooled sample (RR = 2.469, 95% confidence interval = 1.848-3.300). Age did not significantly modify the RR.
MVP is significantly more prevalent in patients with PD than in controls. This meta-analysis of published studies is sufficient to establish an association between PD and MVP; nevertheless, it is not clear that the association is specific to PD. Patients with PD should be evaluated for MVP to decrease possible negative adverse consequences of MVP.
尽管大多数研究表明,二尖瓣脱垂(MVP)在惊恐障碍(PD)患者中比健康对照组更为常见,但在不同研究中 MVP 的发生率存在很大的不确定性。
通过系统评价和荟萃分析,调查 PD 患者与对照组相比 MVP 的相对风险。
检索 Embase、Proquest、Pubmed 和 Google Scholar 电子数据库,检索时间截至 2018 年 9 月。纳入包含 PD 和对照组的同行评议期刊上发表的所有研究。记录 PD 和对照组中 MVP 的发生情况(存在 MVP)和未发生情况(不存在 MVP)。主要结局为使用固定效应模型计算并合并 95%置信区间的相对风险(RR)。评估异质性、小样本发表偏倚和发表偏倚。
符合纳入标准的研究有 14 项,共纳入 1146 名参与者。无显著异质性或发表偏倚。PD 患者中 MVP 的发生率为 27.20%,健康对照组为 9.21%。与对照组相比,PD 患者 MVP 的相对风险显著增加(RR=2.469,95%置信区间=1.848-3.300)。年龄未显著改变 RR。
PD 患者中 MVP 明显更为常见。本荟萃分析的发表研究足以确定 PD 与 MVP 之间存在关联;然而,尚不清楚这种关联是否特定于 PD。应评估 PD 患者是否存在 MVP,以降低 MVP 可能带来的负面不良后果。